Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.1%

- Check22 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.4.2. The previous Revision: v3.4.1 notice and the government funding lapse notice were removed.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, warning that information may not be up to date and transactions may not be processed (with links to cc.nih.gov and opm.gov). Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check65 days agoChange DetectedMinor UI and metadata updates include showing the glossary toggle, capitalization/style changes for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to core study details in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.